Evidence map›Paper›PMID 25447732›Full record

ReviewInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2014

Role of innate immunity in the pathogenesis of otitis media.

Rahul Mittal, Joyson Kodiyan, Robert Gerring, Kalai Mathee, Jian-Dong Li, M'hamed Grati, Xue Zhong Liu

Open access · goldAbstract readReview
In one paragraph

Review in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Dysregulation of immune response in otitis media.Expert reviews in molecular medicine · 2021
    Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Infectious medicine · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. The Roles of NOD-like Receptors in Innate Immunity in Otitis Media.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Innate Immunity in the Middle Ear Mucosa.Frontiers in cellular and infection microbiology · 2021
    Review
  19. Leukotriene B4 Is a Major Determinant of Leukocyte Recruitment During Otitis Media.Frontiers in cellular and infection microbiology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rahul MittalDepartment of Otolaryngology, University of Miami - Miller School of Medicine, 1601 NW 12th Avenue, Miami, FL 33136, USA.
Joyson KodiyanDepartment of Otolaryngology, University of Miami - Miller School of Medicine, 1601 NW 12th Avenue, Miami, FL 33136, USA.
Robert GerringDepartment of Otolaryngology, University of Miami - Miller School of Medicine, 1601 NW 12th Avenue, Miami, FL 33136, USA.
Kalai MatheeDepartment of Human and Molecular Genetics, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA.
Jian-Dong LiCenter for Inflammation, Immunity, and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA.
M'hamed GratiDepartment of Otolaryngology, University of Miami - Miller School of Medicine, 1601 NW 12th Avenue, Miami, FL 33136, USA.
Xue Zhong LiuDepartment of Otolaryngology, University of Miami - Miller School of Medicine, 1601 NW 12th Avenue, Miami, FL 33136, USA. Electronic address: xliu@med.miami.edu.
Florida International University · USGeorgia State University · US

Funding

Molecular Genetics on Non Syndromic Hearing Loss (NSHL)R01DC005575 · NIDCD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LIU, XUE Z · 2001 to 2024
$10.6M
Sensory disorders in COVID -19 as an early identifier and healthcare worker protectionR01DC012115 · NIDCD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LIU, XUE Z · 2013 to 2022
$7.2M
Molecular Genetics of autosomal dominant non-syndromic hearing lossR01DC012546 · NIDCD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LIU, XUE Z · 2012 to 2016
$1.6M
NIDCD NIH HHS R01 DC005575NIDCD NIH HHS R01 DC012115NIDCD NIH HHS R01 DC01246NIDCD NIH HHS R01 DC012546NIDCD NIH HHS R01 DC05575
6 · The paper itself

Abstract

Otitis media (OM) is a public health problem in both developed and developing countries. It is the leading cause of hearing loss and represents a significant healthcare burden. In some cases, acute OM progresses to chronic suppurative OM (CSOM), characterized by effusion and discharge, despite antimicrobial therapy. The emergence of antibiotic resistance and potential ototoxicity of antibiotics has created an urgent need to design non-conventional therapeutic strategies against OM based on modern insights into its pathophysiology. In this article, we review the role of innate immunity as it pertains to OM and discuss recent advances in understanding the role of innate immune cells in protecting the middle ear. We also discuss the mechanisms utilized by pathogens to subvert innate immunity and thereby overcome defensive responses. A better knowledge about bacterial virulence and host resistance promises to reveal novel targets to design effective treatment strategies against OM. The identification and characterization of small natural compounds that can boost innate immunity may provide new avenues for the treatment of OM. There is also a need to design novel methods for targeted delivery of these compounds into the middle ear, allowing higher therapeutic doses and minimizing systemic side effects.

Indexed as

Immunity, InnateEar, MiddleHumansOtitis MediaEpithelial cellsInnate immunityMucinOtitis media

Identifiers

PMID25447732
PMCPMC4310697
OpenAlexW1979816988

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.